Poland· PL-100036638

Lakcid

A antidiarrheal microorganisms product containing lactobacillus rhamnosus, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 4 of our 19 countries.

ATC A07FA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLakcidATCA07FAREGISTER NO.PL-100036638PACKS LISTED10CHECKEDSeptember 27, 2026

Where it is registered

Lactobacillus rhamnosus is registered in 4 of 19 countries.

Countries holding a registration under ATC A07FA (antidiarrheal microorganisms), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Lactobacillus rhamnosus · ATC A07FA

4 / 19 countries

  • Finlandprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Lactobacillus rhamnosus
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
A07FA
ATC class
Antidiarrheal microorganisms
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 10

  • gtin
    05909990322817
  • gtin
    05909990322824
  • gtin
    05909990641208
  • gtin
    05909990744077
  • gtin
    05909990744084
  • gtin
    05909990820399
  • gtin
    05909990820405
  • gtin
    05909990820436
  • gtin
    05909990820443
  • gtin
    05909990820450

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lactobacillus rhamnosus in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lactobacillus rhamnosus products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Austria · Antibiophilus, Gynophilus
  • Germany · Infectodiarrstop Lgg Mono Beutel Für Säuglinge Und Kleinkinder
  • France · Lenia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e46f8e76-6328-4119-b30c-3addf24c5e23
GET /v1/drugs/e46f8e76-6328-4119-b30c-3addf24c5e23?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania zawiesiny doustnej",
  "source": "urpl",
  "strength": "minimum 2 mld CFU pałeczek Lactobacillus rhamnosus",
  "packaging": "05909990322817 ¦ OTC ¦ 5632\n10 amp. 2 ml proszku po 1 dawce\n05909990322824 ¦ OTC ¦ 5633\n50 amp. 2 ml proszku po 1 dawce\nRp ¦ Skasowane ¦ 5634\n200 amp. \n05909990641208 ¦ OTC ¦ 42819\n10 amp. 2 ml proszku po 1 dawce + pipeta\n05909990744077 ¦ OTC ¦ 54415\n10 fiol.  proszku po 1 dawce\n05909990744084 ¦ OTC ¦ 54416\n50 fiol. 3 ml proszku po 1 dawce\n05909990820399 ¦ OTC ¦ 61650\n20 amp. 2 ml proszku po 1 dawce\n05909990820405 ¦ OTC ¦ 61651\n20 fiol. 3 ml proszku po 1 dawce\n05909990820436 ¦ OTC ¦ 61652\n10 sasz.  proszku po 1 dawce\n05909990820443 ¦ OTC ¦ 61653\n20 sasz.  proszku po 1 dawce\n05909990820450 ¦ OTC ¦ 61657\n50 sasz.  proszku po 1 dawce",
  "substance": "Lactobacillus rhamnosus 100 mln. komórek",
  "common_name": "Lactobacillus rhamnosus",
  "pl_product_id": "100036638",
  "pozwolenie_nr": "03228",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about lactobacillus rhamnosus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.